Stock Events

Stock Events

Acelrx Pharmaceuticals 

€0.000000
65
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19AugExpected
Q1 2026
Next
-0.06
-0.05
-0.04
-0.03
Expected EPS
-0.054721875
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow R5X.MU. It's not an investment recommendation.
Rocket Lab
5
RKLB
Microsoft
4
MSFT
Tesla
4
TSLA
Amazon
4
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. is a leading global biopharmaceutical company that competes with Talphera in the development and marketing of prescription medicines, vaccines, biologic therapies, and animal health products.
Pfizer
PFE
Mkt Cap138.61B
Pfizer Inc. is a global pharmaceutical corporation which competes directly with Talphera in various therapeutic areas, including oncology, rare diseases, and immunology.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Talphera in the discovery, development, and delivery of innovative medicines that help patients prevail over serious diseases.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, competing with Talphera in the fields of antiviral drugs, cancer, and other diseases.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Talphera in areas such as immunology and oncology.
AMGEN
AMGN
Mkt Cap201.93B
Amgen Inc. is one of the world's leading biotechnology companies, competing with Talphera in developing innovative human therapeutics, including treatments for serious illnesses.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson is a comprehensive healthcare company that competes with Talphera through its pharmaceutical segment, developing drugs for a wide range of medical conditions.
Novartis
NVS
Mkt Cap305.1B
Novartis AG is a global healthcare company based in Switzerland that competes with Talphera in researching, developing, manufacturing, and marketing a broad range of healthcare products.
Roche
RHHBY
Mkt Cap341.62B
Roche Holding AG is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Roche competes with Talphera in the pharmaceutical sector, particularly in oncology and virology.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company that competes with Talphera in developing and commercializing prescription medicines for several therapeutic areas, including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

About

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
Show more...
CEO
Mr. Vincent J. Angotti
Employees
12
Country
United States
ISIN
US00444T1007

Listings

MU
DE
R5X.MU
F
DE
R5XA.F
STU
DE
R5XA.STU
XNAS
US
TLPH

0 Comments

Share your thoughts

FAQ

What is Acelrx Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Acelrx Pharmaceuticals stocks are traded under the ticker R5X.MU.
When is the next Acelrx Pharmaceuticals earnings date?▼
Acelrx Pharmaceuticals is going to release the next earnings report on August 19, 2026.
What were Acelrx Pharmaceuticals earnings last quarter?▼
R5X.MU earnings for the last quarter are -0.03 EUR per share, whereas the estimation was -0.06 EUR resulting in a +40% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Acelrx Pharmaceuticals have?▼
As of July 09, 2026, the company has 12 employees.
In which sector is Acelrx Pharmaceuticals located?▼
Acelrx Pharmaceuticals operates in the Health & Wellness sector.
When did Acelrx Pharmaceuticals complete a stock split?▼
Acelrx Pharmaceuticals has not had any recent stock splits.
Where is Acelrx Pharmaceuticals headquartered?▼
Acelrx Pharmaceuticals is headquartered in San Mateo, United States.